No Data
No Data
Earnings Preview: EBS to Report Financial Results Post-market on March 03
Emergent BioSolutions Inc. (NYSE:EBS) Looks Inexpensive After Falling 33% But Perhaps Not Attractive Enough
Deregulation Exposure Was the Most Valuable Characteristic of a Stock Owned by Hedge Funds – GS
Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
10 Health Care Stocks With Whale Alerts In Today's Session
Is Emergent BioSolutions (NYSE:EBS) Using Too Much Debt?